Evicto
| Species | Dogs and cats. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Composition | EVICTO 15 mg for cats and dogs Solution 60 mg/ml selamectin 15 mg EVICTO 30 mg for dogs Solution 120 mg/ml selamectin 30 mg EVICTO 45 mg for cats Solution 60 mg/ml selamectin 45 mg EVICTO 60 mg for cats Solution 60 mg/ml selamectin 60 mg EVICTO 60 mg for dogs Solution 120 mg/ml selamectin 60 mg EVICTO 120 mg for dogs Solution 120 mg/ml selamectin 120 mg EVICTO 240 mg for dogs Solution 120 mg/ml selamectin 240 mg EVICTO 360 mg for dogs Solution 120 mg/ml selamectin 360 mg |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Indications |
For the treatment and prevention of flea infestations produced by Ctenocephalides spp. for a period of one month after a single administration. This indication is the result of the adulticidal, larvicidal and ovicidal properties of this product. The product has an ovicidal action for a period of 3 weeks after administration. Due to the reduction in the flea population, the monthly treatment of pregnant and lactating animals will also help prevent flea infestation in puppies up to seven weeks of age. For the prevention of heartworm disease - Dirofilaria immitis, by administration Treatment of ringworm (Otodectes cynotis). |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Dosage and method of administration |
Spot-on administration. It will be applied topically, on the surface of the skin, at the base of the neck, in front of the space between the shoulder blades. The product will be administered in accordance with the following table:
Treatment and prevention of flea infestations (cats and dogs). Animals older than six weeks of age: For the prevention of flea infestation, the veterinary medicinal product must be administered at monthly intervals during the flea season, starting one month before the fleas become active. For use as part of a flea allergy dermatitis treatment strategy, the veterinary medicinal product should be administered at monthly intervals.
Prevention of heartworm disease (cats and dogs)
Treatment of hematophagous lice (cats and dogs) Treatment of auricular mange (cats) Treatment of auricular mange (dogs) Treatment of hookworm infestations (cats) Treatment of sarcoptic mange (dogs) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Contraindications | It will not be used in animals less than 6 weeks old. It will not be administered to cats suffering from other diseases, weak or underweight (weight or age). Do not use in cases of hypersensitivity to the active substance or to any of the excipients. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Waiting period |
0 days. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Release form | 1 pipette of EVICTO 15 mg for dogs and cats contains 0.25 ml of solution 60 mg/ml 1 pipette of EVICTO 45 mg for cats contains 0.75 ml of 60 mg/ml solution 1 pipette of EVICTO 60 mg for cats contains 1.0 ml of solution 60 mg/ml 1 pipette of EVICTO 30 mg for dogs contains 0.25 ml of solution 120 mg/ml 1 pipette of EVICTO 60 mg for dogs contains 0.5 ml of solution 120 mg/ml 1 pipette of EVICTO 120 mg for dogs contains 1.0 ml of solution 120 mg/ml 1 pipette of EVICTO 240 mg for dogs contains 2.0 ml of solution 120 mg/ml 1 pipette of EVICTO 360 mg for dogs contains 3.0 ml of a 120 mg/ml solution |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Storage conditions | Store in a dark place, separate from food and feed, at T°C 5°C + 25°C, in places inaccessible to children. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shelf life |
2 years from the date of production. Do not use after the expiry date indicated on the packaging. |
